About KAI Conversations
KAI Conversations is a Healthcare company based in Windsor (United Kingdom) founded in 2020. It operates as a conversational intelligence insights are provided for healthcare and pharma sectors. KAI Conversations offers products and services including Customer Insights, Salesforce Effectiveness, Healthcare Services, and Coaching Services. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its legal entity is KAI Conversations Limited. Its competitors include Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Humaneva Group and 2 more; 6 of its 7 listed competitors have raised funding.
Company details
Provider of conversational intelligence insights for healthcare and pharma. This company analyzes conversations to provide actionable insights. For pharmaceutical organizations, it offers marketing and sales force effectiveness analysis to better understand healthcare professional needs and improve market access. In healthcare, it improves patient outcomes by keeping patients out of acute care and enhancing healthcare professional emotional intelligence. The company also offers customer insights, salesforce effectiveness monitoring, healthcare services, and coaching services, all based on analyzing conversations to reveal hidden human insights.
- Headquarters Windsor, United Kingdom
- SectorsHealthcare
- Email••••••••
- Website kaiconversations.com
- Social LinkedIn
- Legal Name Kai Conversations Limited
- Investors
Products & Services of KAI Conversations
KAI Conversations offers a comprehensive portfolio of products and services, including Customer Insights, Salesforce Effectiveness, Healthcare Services, and Coaching Services.
Delivers insights on customer message reception and feelings.
Tracks sales team performance in real-time for optimization.
Offers insights to improve remote patient care and outcomes.
Identifies opportunities for learning and monitors improvements.
Funding Insights of KAI Conversations
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of KAI Conversations with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2025 | – | Seed | – | ScaleUp Group | – |
1 investors in total: 1 institutional.
Investors in KAI Conversations
KAI Conversations has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ScaleUp Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Helps B2B SaaS scaleups secure Series A funding from suitable investors. | 2015 | scaleupgroup.co | London, United Kingdom |
Investor details for KAI Conversations
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of KAI Conversations
2 dated milestones of KAI Conversations across 5 years, from founding to its latest funding, stage changes and deals.
- Founded KAI Conversations is founded.
- Funding First funding round.
Competitors of KAI Conversations
KAI Conversations has 7 listed competitors in our database, 6 of them funded. They include Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Humaneva Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| faunabio.com | 2018 | Berkeley, United States | $13.1M | 19 | Animal genomics is applied to healthcare advancements by Fauna Bio. | |
| beaconcure.com | 2016 | Tel Aviv, Israel | $40.92M | – | Data analytics and validation software for regulatory submission in the healthcare sector | |
| predxbio.com | 2017 | Pittsburgh, United States | $1.4M | – | AI-based drug discovery and clinical services are provided for biopharma. | |
| lila.ai | 2023 | – | $550M | – | AI-powered platforms for autonomous scientific research are developed. | |
| humaneva.com | 2014 | Raleigh, United States | $50M | – | Provider of clinical research data services for oncology & other therapeutic areas | |
| privatehealth.com | 2007 | Los Angeles, United States | – | – | Provides personalized healthcare guidance for complex diseases and partnerships. | |
| rgnmed.com | 2014 | Greenwich, United States | $290,000 | – | Healthcare data analytics company that enables clinical and financial value creation for clinicians |
Detailed competitors of KAI Conversations
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as KAI Conversations (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kai Conversations
Complete news archive for KAI Conversations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KAI Conversations
KAI Conversations was founded in 2020 and raised its 1st funding round 5 years after it was founded.
KAI Conversations is headquartered in Windsor, United Kingdom.
Provider of conversational intelligence insights for healthcare and pharma. This company analyzes conversations to provide actionable insights. For pharmaceutical organizations, it offers marketing and sales force effectiveness analysis to better understand healthcare professional needs and improve market access. In healthcare, it improves patient outcomes by keeping patients out of acute care and enhancing healthcare professional emotional intelligence. The company also offers customer insights, salesforce effectiveness monitoring, healthcare services, and coaching services, all based on analyzing conversations to reveal hidden human insights.
KAI Conversations's top competitors include Fauna Bio, Predxbio and Lila Sciences.
KAI Conversations offers Customer Insights, Salesforce Effectiveness, Healthcare Services, and Coaching Services.
KAI Conversations has 1 investor. Key investors include ScaleUp Group.
KAI Conversations operates through Kai Conversations Limited.